Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Retained Earnings at End of Quarter (QFRD123385USNO)

Observations

Q2 2026: 412,157
Updated: Sep 8, 2026 9:12 AM CDT
Next Release Date: Dec 7, 2026
Q2 2026:  412,157  
Q1 2026:  417,913  
Q4 2025:  415,018  
Q3 2025:  426,992  
Q2 2025:  394,411  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Retained Earnings at End of Quarter [QFRD123385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFRD123385USNO, .

Release Tables

Quarterly Financial Report

Related Data and Content

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Financial Activity Measures Financial Indicators Money, Banking, & Finance

Releases

More Series from Quarterly Financial Report

Tags

retained earnings Medicines Pharmaceuticals Quarterly Financial Report Chemicals Nondurable Goods Finance Earnings Corporate Goods Manufacturing Industry Census Quarterly Nation Public Domain: Citation Requested United States of America Not Seasonally Adjusted

Back to Top

Subscribe to the FRED newsletter

Follow us

 

Need Help?

Questions or Comments
FRED Help
Legal
Privacy Notice & Policy